Mirum Pharmaceuticals traded as high as $98.49 and last traded at $96.92, with a volume of 882340 shares. Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) last released its quarterly earnings data on Tuesday, November 4th. On average, analysts expect that Mirum Pharmaceuticals, Inc. will post -1.43 EPS for the current fiscal year. Mirum Pharmaceuticals Company Profile(Get Free Report)Mirum Pharmaceuticals, Inc is a late-stage biopharmaceutical company dedicated to the development and commercialization of innovative therapies for rare cholestatic liver diseases. Featured StoriesReceive News & Ratings for Mirum Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirum Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.